| Literature DB >> 26644582 |
Tielin Zhou1, Jing Li2, Peiquan Zhao2, Huijuan Liu3, Deyong Jia4, Hao Jia3, Lin He3, Yong Cang5, Sharon Boast6, Yi-Han Chen7, Hélène Thibault8, Marielle Scherrer-Crosbie8, Stephen P Goff9, Baojie Li10.
Abstract
Protein palmitoylation regulates many aspects of cell function and is carried out by acyl transferases that contain zf-DHHC motifs. The in vivo physiological function of protein palmitoylation is largely unknown. Here we generated mice deficient in the acyl transferase Aph2 (Ablphilin 2 or zf-DHHC16) and demonstrated an essential role for Aph2 in embryonic/postnatal survival, eye development, and heart development. Aph2(-/-) embryos and pups showed cardiomyopathy and cardiac defects including bradycardia. We identified phospholamban, a protein often associated with human cardiomyopathy, as an interacting partner and a substrate of Aph2. Aph2-mediated palmitoylation of phospholamban on cysteine 36 differentially alters its interaction with PKA and protein phosphatase 1 α, augmenting serine 16 phosphorylation, and regulates phospholamban pentamer formation. Aph2 deficiency results in phospholamban hypophosphorylation, a hyperinhibitory form. Ablation of phospholamban in Aph2(-/-) mice histologically and functionally alleviated the heart defects. These findings establish Aph2 as a critical in vivo regulator of cardiac function and reveal roles for protein palmitoylation in the development of other organs including eyes.Entities:
Keywords: Aph2 gene; cardiac development; eye development; palmitoyl transferase; phospholamban
Mesh:
Substances:
Year: 2015 PMID: 26644582 PMCID: PMC4697436 DOI: 10.1073/pnas.1518368112
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205